Tert-butyl N-[(E)-3-fluoro-2-[[4-(4-methyl-5-morpholin-4-yl-1,3-thiazol-2-yl)phenoxy]methyl]prop-2-enyl]carbamate
C23H30FN3O4S — CID 146512195
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[(E)-3-fluoro-2-[[4-(4-methyl-5-morpholin-4-yl-1,3-thiazol-2-yl)phenoxy]methyl]prop-2-enyl]carbamate
Tert-butyl N-[(E)-3-fluoro-2-[[4-(4-methyl-5-morpholin-4-yl-1,3-thiazol-2-yl)phenoxy]methyl]prop-2-enyl]carbamate (PubChem CID 146512195) has the molecular formula C23H30FN3O4S and a molecular weight of 463.58 g/mol. Its IUPAC name is tert-butyl N-[(E)-3-fluoro-2-[[4-(4-methyl-5-morpholin-4-yl-1,3-thiazol-2-yl)phenoxy]methyl]prop-2-enyl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[(E)-3-fluoro-2-[[4-(4-methyl-5-morpholin-4-yl-1,3-thiazol-2-yl)phenoxy]methyl]prop-2-enyl]carbamate |
|---|---|
| PubChem CID | 146512195 |
| Molecular Formula | C23H30FN3O4S |
| Molecular Weight | 463.58 g/mol |
| Exact Mass | 463.19 |
| IUPAC Name | tert-butyl N-[(E)-3-fluoro-2-[[4-(4-methyl-5-morpholin-4-yl-1,3-thiazol-2-yl)phenoxy]methyl]prop-2-enyl]carbamate |
| SMILES | Cc1nc(-c2ccc(OC/C(=C/F)CNC(=O)OC(C)(C)C)cc2)sc1N1CCOCC1 |
| InChI | InChI=1S/C23H30FN3O4S/c1-16-21(27-9-11-29-12-10-27)32-20(26-16)18-5-7-19(8-6-18)30-15-17(13-24)14-25-22(28)31-23(2,3)4/h5-8,13H,9-12,14-15H2,1-4H3,(H,25,28)/b17-13+ |
| InChIKey | WPIADCFTUBCXIG-GHRIWEEISA-N |
| XLogP | 4.71 |
| TPSA | 72.92 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 463.58 |
| LogP ≤ 5 | 4.71 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146512195 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.